The Need for a Quality Control of the Whole Process of Immunohistochemistry Human Epidermal Growth Factor Receptor 2/neu Determination: A United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers Pilot Experience-Reference-Cited by-同舟云学术

The Need for a Quality Control of the Whole Process of Immunohistochemistry Human Epidermal Growth Factor Receptor 2/neu Determination: A United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers Pilot Experience

Published:2007-08-01 Issue:22 Volume:25 Page:e27-e28
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Paradiso Angelo¹,Miller Keith²,Marubini Ettore³,Pizzamiglio Sara⁴,Verderio Paolo⁴

Affiliation:

1. Italian Network for Quality Assessment of Tumor Biomarkers-Coordinating Unit, National Cancer Institute, Bari, Italy

2. United Kingdom National External Quality Assessment Service Immunocitochemistry and Fluorescence In Situ Hybridization Histopathology, University College London, London, United Kingdom

3. Italian Network for Quality Assessment of Tumor Biomarkers-Biostatistics Unit, Institute of Medical Statistics and Biometry, University of Milan, Milan, Italy

4. Italian Network for Quality Assessment of Tumor Biomarkers-Biostatistics Unit, Istituto Nazionale dei Tumori, Milan, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.10.5155

Reference9 articles.

1. Docetaxel (taxotere) plus trastuzumab (herceptin) in breast cancer

2. Birner P, Oberhuber G, Stani J, et al: Evaluation of the USA FDA-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7:1669,2001-1675,

3. The clinical evaluation of HER-2 status: which test to use?

4. HER2Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

5. Interobserver Reproducibility of Immunohistochemical Her-2/Neu Evaluation in Human Breast Cancer: The Real-World Experience

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002;Oncology Letters;2020-07-01

2. Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy;Therapeutic Advances in Urology;2018-10-24

3. Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots;Asian Journal of Urology;2017-10

4. Intermittent Versus Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer: Review;Üroonkoloji Bülteni;2015-06-05

5. A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies;Critical Reviews in Oncology/Hematology;2013-10